This inventor holds 1 USPTO granted patent, plus 3 CIPO patents and 1 EPO patent. Top assignee: National Research Council of Canada. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Dennis Sprott: Innovator in Synthetic Archaeal Glycolipid Adjuvants
Introduction
Dennis Sprott is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of immunology through his innovative work on synthetic archaeal glycolipid adjuvants. His research focuses on enhancing immune responses using novel lipid formulations.
Latest Patents
Dennis Sprott holds 1 patent for his invention titled "Synthetic archaeal glycolipid adjuvants." This patent describes a method for synthesizing archaeal lipid adjuvants by chemically coupling various carbohydrates or anionic polar groups to the free hydroxyl(s) of archaeal lipid cores. The invention utilizes chemically stable lipid cores, such as saturated archaeol and caldarchaeol, obtained from appropriate Archaea. The resulting archaeosome lipid vesicles are formulated from synthetic lipids designed to serve as antigen carriers, targeting antigen-presenting cells and promoting an appropriate immune response.
Career Highlights
Dennis Sprott is affiliated with the National Research Council of Canada, where he continues to advance research in the field of immunology. His work has implications for vaccine development and therapeutic applications, showcasing his commitment to scientific innovation.
Collaborations
Throughout his career, Dennis has collaborated with esteemed colleagues, including Lakshmi Krishnan and Dennis M. Whitfield. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.
Conclusion
Dennis Sprott's contributions to the field of synthetic archaeal glycolipid adjuvants exemplify the impact of innovative research on immunology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.